During the last session, Theratechnologies Inc (NASDAQ:THTX)’s traded shares were 0.82 million, with the beta value of the company hitting 1.04. At the end of the trading day, the stock’s price was $1.50, reflecting an intraday loss of -10.18% or -$0.17. The 52-week high for the THTX share is $2.18, that puts it down -45.33 from that peak though still a striking 28.0% gain since the share price plummeted to a 52-week low of $1.08. The company’s market capitalization is $36.30M, and the average intraday trading volume over the past 10 days was 5.77 million shares, and the average trade volume was 1.04 million shares over the past three months.
Theratechnologies Inc (THTX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. THTX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
Theratechnologies Inc (NASDAQ:THTX) trade information
Theratechnologies Inc (THTX) registered a -10.18% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -10.18% in intraday trading to $1.50, hitting a weekly high. The stock’s 5-day price performance is -5.06%, and it has moved by -7.41% in 30 days. Based on these gigs, the overall price performance for the year is 6.38%. The short interest in Theratechnologies Inc (NASDAQ:THTX) is 41858.0 shares and it means that shorts have 0.33 day(s) to cover.
Theratechnologies Inc (THTX) estimates and forecasts
In the rating firms’ projections, revenue will increase 2.32% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 29.18M as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 28.01M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 22.08M and 30.05M respectively. In this case, analysts expect current quarter sales to grow by 32.15% and then drop by -6.76% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 23.68%. While earnings are projected to return 176.47% in 2025.
THTX Dividends
Theratechnologies Inc is due to release its next quarterly earnings on 2025-Feb-25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Theratechnologies Inc (NASDAQ:THTX)’s Major holders
Theratechnologies Inc insiders own 1.15% of total outstanding shares while institutional holders control 50.11%, with the float percentage being 50.69%. MAI CAPITAL MANAGEMENT is the largest shareholder of the company, while 50.0 institutions own stock in it. As of 2024-06-30, the company held over 29242.0 shares (or 0.0636% of all shares), a total value of $40939.0 in shares.
Data provided on Dec 31, 2024 indicates that Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund owns about 25.68 shares. This amounts to just over 0.06 percent of the company’s overall shares, with a $38521.0 market value.
